Pharmaceutical preparations company · DE · FY ends Dec · -3242.47% margin · -$9M FCF
The business is unprofitable at the operating level (-3242.47% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
ROIC dropped from -17.28% to -22.16%, capital efficiency is deteriorating. Negative free cash flow of -$10M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (FY)
$410K
Net Income (TTM)
-$12M
▼ -8.6% YoY
Op. Margin
-3242.47%
ROIC
-23.63%
▼ -4.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$9M
▲ +7.8% YoY
Op. Cash Flow (TTM)
-$9M
▲ +7.8% YoY
Net Debt
-$27M
Net Cash Position
Cash & Equiv.
$27M
Continue Research